Sarah Hollingsworth "Holly" Lisanby, MD, an internationally renowned innovator of neuromodulation technologies, is Director of the Division of Translational Research at the National Institute of Mental Health (NIMH). As Division Director, she is responsible for managing a portfolio of approximately $400 Million to support research directed towards the discovery of preventions, treatments, and cures for mental illness across the lifespan. She founded and directs the Noninvasive Neuromodulation Unit in the NIMH Intramural Research Program, a pioneering translational research program specializing in the use of brain stimulation tools to measure and modulate neuroplasticity to improve mental health. Previously, she held the JP Gibbons Endowed Professorship with Tenure and was the first woman to serve as Chair of the Duke Department of Psychiatry, a position she held for 5 years prior to being recruited to the NIMH. She founded and directed both the Duke University and the Columbia University Divisions of Brain Stimulation, where she built interdisciplinary research programs specializing in the convergence of Psychiatry, Neuroscience and Engineering. She co-led the NIH BRAIN Initiative Team focused on large-scale neural recording and modulation devices. Dr. Lisanby's laboratory has been continuously federally funded for over 20 years. She has been principal investigator on a series of NIH and DARPA funded studies on the development of novel neuromodulation technologies.